Prnewswireยท2025-10-28 12:30Core Viewpoint - Two Seas Capital LP opposes the proposed acquisition of Core Scientific by CoreWeave, arguing that it does not maximize shareholder value and urging shareholders to vote against the transaction [2][3][4] Company Prospects - Core Scientific is viewed as a best-in-class asset with low-cost power access, site construction expertise, strong infrastructure, and a promising future pipeline [3] - The company is expected to continue building its 700-megawatt pipeline, secure additional hosting contracts, and expand its footprint through existing data centers and new sites [3] Market Context - Since the announcement of the transaction in July 2025, investment in AI infrastructure has surged, leading to increased equity valuations for Core Scientific's peers [3] - If Core Scientific's stock traded in line with its peers, it would be valued at more than double the proposed transaction price of $16.40 per share [3] Shareholder Action - The vote on the CoreWeave transaction is scheduled for October 30, 2025, and shareholders are encouraged to reject the deal to capitalize on growth opportunities in the AI landscape [4][5]